LexDanaLexDanabeta
Inventor

Paul Tavan

Inventor
Munich, DE

Overview

2→
Patents
2018–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
G01NInvestigating or analysing materials by determining their chemical or physical properties25%
PatentTitleYear
10,435,373Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases201910,071,966Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases2018

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2018–2019Patents assigned to MAX PLANCK GESELLSCHAFT (2)· patent assignee history
2018Patents assigned to LUDWIG MAXIMALIANS UNIV MUNCHEN (1)· patent assignee history
2018Patents assigned to UNIV MUENCHEN LUDWIG MAXIMILIANS (1)· patent assignee history
2018Based in München, DE· patent location history
2019Patents assigned to LUDWIG MAXIMILIANS UNIV MUNCHEN (1)· patent assignee history
2019Based in Munich, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MAX PLANCK GESELLSCHAFT22018–2019
LUDWIG MAXIMALIANS UNIV MUNCHEN12018
LUDWIG MAXIMILIANS UNIV MUNCHEN12019
UNIV MUENCHEN LUDWIG MAXIMILIANS12018
Locations
LocationPatentsSpan
Munich, DE12019
München, DE12018